Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilitiesby applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.

Health Care

Beactica Therapeutics

Beactica Therapeutics' headquarters in Uppsala, Sweden

Description

People (8)

Per Källblad

Johan Winquist

Konrad Koehler

Peter Brandt

Gun Stenberg

Matthis Geitmann

Rajiv Sawant

Wei Berts

Jobs